Healthcare provider profile · identity verified

Syeda Simra Khusro

Hospitalist · LAS VEGAS, NV · NPI 1912389396

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	325	128
Losartan Potassium	Losartan Potassium	211	72
Levothyroxine Sodium	Levothyroxine Sodium	170	70
Rosuvastatin Calcium	Rosuvastatin Calcium	169	71
Amlodipine Besylate	Amlodipine Besylate	167	72
Lisinopril	Lisinopril	143	54
Metformin Hcl	Metformin Hcl	127	47
Gabapentin	Gabapentin	102	34
Albuterol Sulfate Hfa	Albuterol Sulfate	93	40
Simvastatin	Simvastatin	87	32
Omeprazole	Omeprazole	85	41
Atenolol	Atenolol	83	28
Glipizide	Glipizide	77	29
Metoprolol Tartrate	Metoprolol Tartrate	70	27
Meloxicam	Meloxicam	61	33
Hydrochlorothiazide	Hydrochlorothiazide	59	21
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	59	15
Jardiance	Empagliflozin	58	20
Tamsulosin Hcl	Tamsulosin Hcl	58	24
Alendronate Sodium	Alendronate Sodium	54	17
Pantoprazole Sodium	Pantoprazole Sodium	51	22
Pradaxa	Dabigatran Etexilate Mesylate	47	21
Trazodone Hcl	Trazodone Hcl	46	17
Metformin Hcl Er	Metformin Hcl	45	18
Pravastatin Sodium	Pravastatin Sodium	36	13
Azithromycin	Azithromycin	35	35
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	35	17
Spiriva Respimat	Tiotropium Bromide	33	suppressed
Alvesco	Ciclesonide	32	27
Cephalexin	Cephalexin	31	26
Propranolol Hcl	Propranolol Hcl	31	suppressed
Furosemide	Furosemide	30	15
Terazosin Hcl	Terazosin Hcl	30	13
Carvedilol	Carvedilol	28	suppressed
Hydrocortisone	Hydrocortisone	28	22
Tramadol Hcl	Tramadol Hcl	25	suppressed
Hydralazine Hcl	Hydralazine Hcl	23	11
Ibuprofen	Ibuprofen	23	suppressed
Lovastatin	Lovastatin	23	suppressed
Sertraline Hcl	Sertraline Hcl	23	suppressed
Allopurinol	Allopurinol	22	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	22	22
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	22	11
Triamcinolone Acetonide	Triamcinolone Acetonide	22	11
Acyclovir	Acyclovir	21	suppressed
Alprazolam	Alprazolam	21	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	21	suppressed
Montelukast Sodium	Montelukast Sodium	21	11
Mupirocin	Mupirocin	20	18
Prednisone	Prednisone	20	20
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	20	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	19	19
Azelastine Hcl	Azelastine Hcl	19	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	19	suppressed
Potassium Chloride	Potassium Chloride	19	12
Clopidogrel	Clopidogrel Bisulfate	18	suppressed
Lactulose	Lactulose	18	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	18	suppressed
Verapamil Er	Verapamil Hcl	18	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	18	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	17	17
Doxycycline Monohydrate	Doxycycline Monohydrate	17	15
Finasteride	Finasteride	17	suppressed
Lorazepam	Lorazepam	17	suppressed
Metoprolol Succinate	Metoprolol Succinate	17	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	17	suppressed
Repatha Sureclick	Evolocumab	17	suppressed
Famotidine	Famotidine	16	11
Ketoconazole	Ketoconazole	16	suppressed
Spironolactone	Spironolactone	16	suppressed
Bumetanide	Bumetanide	15	suppressed
Ezetimibe	Ezetimibe	15	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	15	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	15	suppressed
Duloxetine Hcl	Duloxetine Hcl	14	suppressed
Lidocaine	Lidocaine	14	suppressed
Fluconazole	Fluconazole	13	suppressed
Nystatin	Nystatin	13	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	13	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	13	suppressed
Citalopram Hbr	Citalopram Hydrobromide	12	suppressed
Eliquis	Apixaban	12	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	12	suppressed
Clobetasol Propionate	Clobetasol Propionate	11	suppressed
Clonazepam	Clonazepam	11	suppressed
Pregabalin	Pregabalin	11	suppressed
Veo Insulin Syringe	Syringe And Needle,insulin,1ml	11	suppressed
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error